ArticlePLoS pathogens2025

Divergent resistance pathways amongst SARS-CoV-2 PLpro inhibitors highlight the need for scaffold diversity.

Xinyu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.